Psychoactive Drug Uses Among Medical and Pharmacy Students (PSYCHO'ACT)
6. mai 2022 oppdatert av: University Hospital, Grenoble
Drug addiction to psychoactive substances, widely consumed in France, represents a major public health issue.
The three main motivations identified for the consumption of psychostimulants would be self-medication, the party aspect and the improvement of school performance.
Students of medicine and pharmacy are a population exposed to academic and professional stress, vulnerable to health problems and psycho-social disorders (anxiety, depression), with direct access to many drugs at their workplace.
Almost a third of these students declared to consume these products to improve their cognitive performance, while a recent study showed that they take them instead to manage their stress and sleep.
However, no study has characterized all the different uses of psychoactive drugs (PAD) in this population, nor the motivations for consumption, while an analysis of motives would help to develop better screening and prevention strategies.
The main objective of the research is to characterize the motivations for PAD consumption among students of medicine and pharmacy in France.
The most represented motives will be analyzed on the questionnaire of motivations for consumption (threshold frequency ≥20%).
The secondary objectives are to identify the risk factors linked to the individual, to the environment and to drugs in students with PAD use disorders regardless of their motivation and in those using to improve their performance.
Studieoversikt
Status
Fullført
Studietype
Observasjonsmessig
Registrering (Faktiske)
1930
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Grenoble, Frankrike, 38043
- Grenoble_Alpes UniversityHospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
medical and pharmacy students, from the 2nd to the 6th year, in France
Beskrivelse
Inclusion Criteria:
- Being of legal age
- Studying medicine or pharmacy in France from the 2nd to the 6th year
- Have read the newsletter and validated its no objection
- Have answered all the questions
- Validate the return of the questionnaire
Exclusion Criteria:
- partial filling of the online questionnaire
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The main objective of the research is to characterize the motivations for psychoactive drugs consumption among medical and pharmacy students in France.
Tidsramme: two months
|
frequency of the most represented items concerning the main palatability drug on the Consumption Motivation Screening Questionnaire (frequency threshold considered ≥ 20%). (the minimum value of the questionnaire: 0 motivation of consumption; the maximum value: 110 motivations of consumption, higher scores mean a more severe addiction) |
two months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to the individual (anxiety)
Tidsramme: two months
|
assessment the intensity of anxiety on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)
|
two months
|
|
In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to the individual (depression)
Tidsramme: two months
|
assessment the intensity of depression on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)
|
two months
|
|
In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to the environment
Tidsramme: two months
|
family psychiatric history Psycho'act questionnaire
|
two months
|
|
In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to drugs.
Tidsramme: two months
|
assessment of the intensity of the psychoactive drug use disorder with the Addictive Intensity Evaluation Questionnaire (the minimum value of the questionnaire : 14; the maximum value: 98; higher scores mean a worse outcome)
|
two months
|
|
In students with psychoactive drug use disorder for doping purposes, identify risk factors related to the individual (anxiety)
Tidsramme: two months
|
assessment the intensity of anxiety on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)
|
two months
|
|
In students with psychoactive drug use disorder for doping purposes, identify risk factors related to the individual (depression)
Tidsramme: two months
|
assessment the intensity of depression on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)
|
two months
|
|
In students with psychoactive drug use disorder for doping purposes, identify risk factors related to the environment
Tidsramme: two months
|
family psychiatric history Psycho'act questionnaire
|
two months
|
|
In students with psychoactive drug use disorder for doping purposes, identify risk factors related to drugs.
Tidsramme: two months
|
assessment of the intensity of the psychoactive drug use disorder with the Addictive Intensity Evaluation Questionnaire (the minimum value of the questionnaire : 14; the maximum value: 98; higher scores mean a worse outcome)
|
two months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
24. januar 2022
Primær fullføring (Faktiske)
21. mars 2022
Studiet fullført (Faktiske)
21. mars 2022
Datoer for studieregistrering
Først innsendt
27. september 2021
Først innsendt som oppfylte QC-kriteriene
29. oktober 2021
Først lagt ut (Faktiske)
10. november 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
9. mai 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
6. mai 2022
Sist bekreftet
1. mai 2022
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 38RC20.161
- 2020-A01352-37 (Annen identifikator: ID RCB)
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .